Loading patent…
AssigneeImpel Pharmaceuticals Inc.
InventorsJohn D. Hoekman, Kelsey H. Satterly, Inna Dashevsky, Aditya R. Das, Stephen B. Shrewsbury, Gregory J. Davies, Bhavin Y. Gajera
Estimating the term…
A dry pharmaceutical composition is provided that is suitable for respiratory tract delivery of levodopa and DDI for treatment of Parkinson's disease or Parkinson syndrome. The dry pharmaceutical composition comprises levodopa, a dopa decarboxylase inhibitor (DDI) and at least one excipient. A unit dosage form of the dry pharmaceutical composition and a method of treating a patient with Parkinson's disease or Parkinson syndrome by administering the dry pharmaceutical composition are also provided.
A dry pharmaceutical composition, comprising:
(canceled)
6-16. (canceled)
(canceled)
(canceled)
22-25. (canceled)
27-28. (canceled)
30-31. (canceled)
33-34. (canceled)
36-37. (canceled)
39-40. (canceled)
42-43. (canceled)
45-46. (canceled)
48-50. (canceled)
53-59. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
72-80. (canceled)
The method of claim 80, wherein the step of delivering is performed using a delivery device, wherein the delivery device is (i) a handheld, manually actuated, metered-dose administration device, (ii) a manually actuated, propellant-driven, metered-dose administration device, or (iii) a breath-actuated inhaler.
82-83. (canceled)
Dependencies are inferred from the claim text.